Prostate cancer: Increased dementia risk following androgen deprivation therapy?

Nat Rev Urol. 2016 Apr;13(4):188-9. doi: 10.1038/nrurol.2016.34. Epub 2016 Feb 23.

Authors

Ralph N Martins¹, Sam Gandy²

Affiliations

¹ Centre of Excellence for Alzheimer's Disease Research &Care, School of Medical Sciences, Edith Cowan University, 270 Joondalup Drive, Joondalup, Western Australia 6027, Australia.
² Centre for Cognitive Health and NFL Neurological Care, Icahn School of Medicine at Mount Sinai, 5 East 98th Street, 7th floor, New York, New York 10029, USA.

PMID: 26902342
DOI: 10.1038/nrurol.2016.34

No abstract available

Publication types

Comment

MeSH terms

Alzheimer Disease / epidemiology*
Androgen Antagonists / therapeutic use*
Antineoplastic Agents, Hormonal / therapeutic use*
Electronic Health Records*
Humans
Male
Prostatic Neoplasms / drug therapy*

Substances

Androgen Antagonists
Antineoplastic Agents, Hormonal

Grants and funding

P50 AG005138/AG/NIA NIH HHS/United States